InsidersTradesSigma
Browse the full directors' dealings record of IMMUNE PHARMACEUTICALS INC, a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €245.3m. The latest transaction was filed on 26 January 2016 (Acquisition). Among the most active insiders: Teper Daniel Gedeon. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
IMMUNE PHARMACEUTICALS INC is a biopharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases. It is listed on NASDAQ under the ticker IMNP.